Health

Global Times: Small and mid-sized cities in China go through infection peak, bearing new hope for future

BEIJING, Feb. 1, 2023 /PRNewswire/ -- As media sources around the world have paid so much attention to infection surges in various metropolises or first-and-second-tier cities inChina and governments at all levels have attached great importance to anti-epidemic work in rural areas, a review on ho...

2023-02-01 22:45 2108

Record short videos to assess Parkinson's disease, NERVTEX's First-in-Class AI-based Movement Dysfunction Assessment Software medical device approved

WUHAN, China, Feb. 1, 2023 /PRNewswire/ -- NERVTEX's MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial Intelligence/Machine Learning (AI/ML)- based Software as a Medical Device(SaMD) for the analysis of motor symptoms of Parkinson's disease and other mo...

2023-02-01 22:08 1622

Healint announces a collaboration with University of Toronto, Canada, to study the role of pollution on Migraine

PALO ALTO, Calif., Feb. 1, 2023 /PRNewswire/ -- Healint, the developer and owner of Migraine Buddy – the world's largest migraine tracking and research platform used by more than 3 million people and tens of thousands of migraine and pain clinics – andwww.weather-migraine.com

2023-02-01 22:00 1505

CBC Group Appoints Chief Operating Officer, Strengthening the Firm's Global Operational Capabilities

The former BlackRock and Goldman Sachs executive will oversee the firm's business management functions, including Finance, Human Resources, Legal & Compliance, Branding & Communications, and Technology SINGAPORE, Feb. 1, 2023 /PRNewswire/ -- Singapore-headquartered asset management firm, CBC Gro...

2023-02-01 20:18 1790

HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update

* Full-Year 2022 net revenue of KRW 110 billion, up 8% over 2021 reaching a record high * Strong R&D momentum to continue with batoclimab entering multiple pivotal studies with the first Phase 3 data readout inChina expected in 2023 * Top-line data from tanfanercept's Phase 3 dry eye study e...

2023-02-01 20:00 1731

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

HONG KONG, GERMANTOWN, Md., and SUZHOU, China, Feb. 1, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that it is advancing the clinical development of...

2023-02-01 15:00 3260

THE FARRER PARK COMPANY APPOINTS NEW GROUP CHIEF OPERATING OFFICER AND ACTING GROUP CHIEF EXECUTIVE OFFICER

SINGAPORE, Feb. 1, 2023 /PRNewswire/ -- The Farrer Park Company Pte Ltd (TFPC) announced today the appointment of Ms.Kelly Yang as its Group Chief Operating Officer and Acting Group Chief Executive Officer. Ms. Yang brings to TFPC 23 years of healthcare experience. She was most recently the Chie...

2023-02-01 09:15 3198

Global Times: Having weathered epidemic storms overseas, Chinese return to hometown for safe, joyous Spring Festival reunions

BEIJING, Jan. 31, 2023 /PRNewswire/ -- Red lanterns are once again hung in the contemporary houses that combine Chinese and Western elements in the famous hometown of overseas Chinese in East China'sFujian Province. For countless overseas Chinese, this year's Spring Festival provided an opportun...

2023-01-31 22:10 2139

CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer

SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative therapies for the treatment of hematologic malignancies and solid tumors, has announced CARsgen's execution of a collaboration agreement with F. Hoffmann-La Roche L...

2023-01-31 21:50 2653

Global Times: 'So much better than we had anticipated': China's rural regions embrace Spring Festival as COVID peak ebbs away

BEIJING, Jan. 31, 2023 /PRNewswire/ -- The Spring Festival is rooted in agricultural civilization. Chinese people believe the most traditional atmosphere of Spring Festival is in rural regions. Since the prevention and control of the COVID-19 epidemic has entered a new stage, questions have been...

2023-01-31 21:41 2104

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcome the world's deadliest neglected diseases remained woefully inadequate and largely stagnant. Specific...

2023-01-31 21:30 1778

Guardant Health to integrate Lunit's AI-based scoring algorithm for PD-L1 into its portfolio to enhance cancer biomarker detection

* Powered by Lunit SCOPE PD-L1, the Guardant360 TissueNext PD-L1 test with Guardant Galaxy™ shows improved detection of the biomarker in NSCLC * Lunit's AI solution is the first application in Guardant Galaxy, a suite of AI and other technology tools that enhance Guardant Health's portfolio of...

2023-01-31 21:05 1984

Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China

SHANGHAI, Jan. 31, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that that Chongqing Xinjiang Pharmaceutical Co., Ltd. ("Xinjiang...

2023-01-31 20:30 1642

Appendix 4C - Q2 FY23 Quarterly Cash Flow Report

Highlights: * Expanded participation in ATH434 Phase 2 clinical trial with sites opened for recruitment inAustralia, the United States, and Italy * Presented compelling bioMUSE data at two prestigious industry conferences * Granted a 20-year patent for 100 new compounds targeting Parkinson's...

2023-01-31 20:25 2799

AXA Designated Endoscopy and Day Surgery Centre officially unveils

* Partnering with EC Healthcare to create one-stop services providing health check-ups, medical examinations and treatments * No pre-authorisation required for designated endoscopy and day surgery HONG KONG, Jan. 31, 2023 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") announced the official ...

2023-01-31 18:30 2678

Mindray Unveils Next-generation BeneHeart Defibrillation Solutions to Raise Standards for Resuscitation

SHENZHEN, China, Jan. 31, 2023 /PRNewswire/ -- Mindray, a global leading medical device solutions provider, today announces the launch of next-generation BeneHeart series defibrillators, the BeneHeart D60 and D30. The new BeneHeart defibrillators aim to raise the standards for resuscitation with ...

2023-01-31 18:00 1897

Ascletis Announces U.S. FDA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patients with RSV infection --Preclinical research showed t...

2023-01-31 17:40 2566

Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic

HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donateRMB10...

2023-01-31 16:10 3157

Singleron to present single cell sequencing solutions at the 36th Molecular Biology of Plants Conference

COLOGNE, Germany, Jan. 31, 2023 /PRNewswire/ -- Singleron Biotechnologies , a leader in single cell sequencing, will present at the upcoming 36th Molecular Biology of Plants 2023 (MBP2023) Conference of the Section Plant Physiology and Molecular Biology of the German Socie...

2023-01-31 16:00 1910

Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region

* Daewoong Pharmaceutical to receive up to $76M upfront and development milestone payment plus a double-digit royalties on Net Sales * CS Pharmaceuticals will receive exclusive rights for development and commercialization of Bersiporocin for the treatment of IPF and other respiratory indica...

2023-01-31 14:43 3188
1 ... 212213214215216217218 ... 822